title: Chronodisruption in lung cancer and possible therapeutic approaches.
abstract: A customary temporal organization of physiological functions and biological processes is necessary to maintain body homeostasis and an altered body time structure may favour carcinogenesis. There is growing evidence that GH stimulates cancer growth, IGF1 may have a role in carcinogenesis and cancer promotion, GH-IGF1 axis, TRH, TSH, thyroxine, melatonin and cortisol modulate immune cell function and the immune system is often dysfunctional in patients with malignancies. The aim of our study was to evaluate GH-IGF1 axis, hypothalamus-pituitary-thyroid axis, melatonin, cortisol, lymphocyte subsets and IL2 in lung cancer patients. Peripheral blood samples were collected at 4-hour intervals in a 24-hour period from eleven healthy male subjects (age range 35-53 years) and nine male patients suffering from non-small cell lung cancer (age range 43-63 years). In each blood sample, lymphocyte subpopulations (CD3+, CD4+, CD8+, CD16+, CD20+, CD25+, HLA-DR+, γδTcR bearing cells) were analyzed and GH, IGF1, TRH, TSH, FT4, melatonin, cortisol and IL2 were measured. Circadian rhythmicity was evaluated and MESOR, amplitude and acrophase values were compared. In healthy subjects a significant circadian rhythm could be demonstrated with midday peaks for CD8+, CD16+, γδTCR expressing cells and cortisol, and peaks during the night for CD3+, CD4+, GH, TSH and melatonin. A borderline significant rhythm was also observed for CD20+, with a peak late in the evening. IGF1, TRH, FT4 and IL2 values did not show rhythmic variation. In cancer patients a significant circadian rhythm could be demonstrated with diurnal peak for CD16+ and peaks during the night for CD4+ and melatonin. GH, IGF1, TRH, TSH, FT4, cortisol and IL2 values did not show rhythmic variation. MESOR of CD8+ (P<0.0001), CD20+ (P=0.05), γδTCR expressing cells (P=0.01), IGF1 (P<0.001) and TSH (P=0.032) was higher in healthy subjects, whereas MESOR of CD16+ (P<0.0001), CD25+ (P=0.001), GH (P<0.001), TRH (P=0.002), FT4 (P=0.030), cortisol (P=0.01) and IL2 (P=0.02) was higher in cancer patients. Amplitude of circadian variation of γδTCR expressing cells (P=0.01), TSH (P<0.001) and cortisol (P=0.01) was higher in healthy subjects, whereas amplitude of circadian variation of CD4+ was higher in cancer patients (P=0.02). In conclusion, non-small cell lung cancer patients show severe alterations of periodic and quantitative characteristics of neuroendocrine and immune parameters with loss of circadian rhythmicity and internal desynchronization, leading to chronodisruption.
authors: Department of Internal Medicine and Chronobiology Unit, Scientific Institute and Regional General Hospital "Casa Sollievo della Sofferenza", S. Giovanni Rotondo-FG, Italy. g.mazzoccoli@tin.it
authors: Gianluigi
authors: G
authors: Mazzoccoli
authors: Roberto
authors: R
authors: Tarquini
authors: Tiphanie
authors: T
authors: Durfort
authors: Jean-Christophe
authors: JC
authors: Francois
mesh_terms: D000230:Adenocarcinoma / Q000097:blood / Q000503:physiopathology; D000328:Adult; D002289:Carcinoma, Non-Small-Cell Lung / Q000097:blood / Q000503:physiopathology*; D002294:Carcinoma, Squamous Cell / Q000097:blood / Q000503:physiopathology; D021081:Chronobiology Disorders / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy; D002940:Circadian Rhythm; D006801:Humans; D006854:Hydrocortisone / Q000378:metabolism*; D007030:Hypothalamo-Hypophyseal System / Q000503:physiopathology*; D016130:Immunophenotyping; D036341:Intercellular Signaling Peptides and Proteins / Q000378:metabolism*; D007376:Interleukin-2 / Q000378:metabolism; D008175:Lung Neoplasms / Q000097:blood / Q000503:physiopathology*; D016131:Lymphocyte Subsets / Q000276:immunology; D008297:Male; D008550:Melatonin / Q000378:metabolism*; D008875:Middle Aged; D015213:Neuroimmunomodulation; D010913:Pituitary-Adrenal System / Q000503:physiopathology*; D012636:Secretory Rate
chemical_list: D036341:Intercellular Signaling Peptides and Proteins; D007376:Interleukin-2; D008550:Melatonin; D006854:Hydrocortisone